FTC chair Lina Khan pledges to use all tools to in­ves­ti­gate PBMs

KANSAS CITY, Mo. — Phar­ma­cy ben­e­fit man­agers have be­come a thorn in the side of the phar­ma and in­sur­ance in­dus­tries in re­cent years, and just a cou­ple of months af­ter the Fed­er­al Trade Com­mis­sion sig­naled it would in­ves­ti­gate un­law­ful PBM prac­tices, FTC chair Lina Khan is look­ing to turn up the heat even more.

Khan sat down with Na­tion­al Com­mu­ni­ty Phar­ma­cists As­so­ci­a­tion CEO Dou­glas Hoey on Mon­day morn­ing at the NC­PA’s an­nu­al con­ven­tion, with a fire­side chat in the heart of the Mid­west.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER